BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 20354251)

  • 1. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK; Ho ST; Wong SL
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 5. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.
    Baillargeon J; Kuo YF; Lin YL; Wilkinson GS; Goodwin JS
    Ann Pharmacother; 2011 Oct; 45(10):1199-206. PubMed ID: 21954448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?].
    Urade M
    Clin Calcium; 2010 Nov; 20(11):1740-3. PubMed ID: 21066911
    [No Abstract]   [Full Text] [Related]  

  • 9. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract]   [Full Text] [Related]  

  • 10. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonate-related osteonecrosis of the jaw].
    Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
    Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
    Bagan J; Scully C; Sabater V; Jimenez Y
    Oral Oncol; 2009 Jul; 45(7):551-4. PubMed ID: 19251474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?
    Compston J
    Menopause Int; 2007 Jun; 13(2):54-5. PubMed ID: 17540133
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate related osteonecrosis of the jaws.
    Fung E
    J Rheumatol; 2009 Feb; 36(2):450; author reply 453. PubMed ID: 19208578
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteonecrosis of the Torus Palatinus in the Setting of Long-Term Oral Bisphosphonate Use--A Case Report.
    Ryan JL; Larson E
    S D Med; 2016 Jan; 69(1):23-5. PubMed ID: 26882578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.